OtherCommentary
Mold Control and Detection In Biological Drug Substance Manufacturing Facilities: An Industry Perspective
Anita Bawa, Sophia Asefi, Stephanie Ramsey, Christine Arbesser-Rastburg, Mousumi paul, Francisco Leira, Kim McFarland, Tracy Landeryou, Bindhu Reddy, Marie Murphy, Barbara Daddis, David Baine and Derek Willison-Parry
PDA Journal of Pharmaceutical Science and Technology June 2017, pdajpst.2016.007351; DOI: https://doi.org/10.5731/pdajpst.2016.007351
Anita Bawa
1 Bayer Healthcare;
Sophia Asefi
1 Bayer Healthcare;
Stephanie Ramsey
2 Shire;
Christine Arbesser-Rastburg
2 Shire;
Mousumi paul
3 Merck MSD;
Francisco Leira
4 Lonza;
Kim McFarland
5 Alexion;
Tracy Landeryou
6 Pfizer;
Bindhu Reddy
7 AstraZeneca;
Marie Murphy
8 Eli Lilly;
Barbara Daddis
9 Bristol Meyers Squibb;
David Baine
10 Biophorum Operations Group;
Derek Willison-Parry
11 Biophorum
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 79, Issue 3
May/June 2025
Mold Control and Detection In Biological Drug Substance Manufacturing Facilities: An Industry Perspective
Anita Bawa, Sophia Asefi, Stephanie Ramsey, Christine Arbesser-Rastburg, Mousumi paul, Francisco Leira, Kim McFarland, Tracy Landeryou, Bindhu Reddy, Marie Murphy, Barbara Daddis, David Baine, Derek Willison-Parry
PDA Journal of Pharmaceutical Science and Technology Jun 2017, pdajpst.2016.007351; DOI: 10.5731/pdajpst.2016.007351
Mold Control and Detection In Biological Drug Substance Manufacturing Facilities: An Industry Perspective
Anita Bawa, Sophia Asefi, Stephanie Ramsey, Christine Arbesser-Rastburg, Mousumi paul, Francisco Leira, Kim McFarland, Tracy Landeryou, Bindhu Reddy, Marie Murphy, Barbara Daddis, David Baine, Derek Willison-Parry
PDA Journal of Pharmaceutical Science and Technology Jun 2017, pdajpst.2016.007351; DOI: 10.5731/pdajpst.2016.007351
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.